About Us:

Board of Directors

jbarkerJohn E. Barker
Audit Committee Chair & Independent Director

Mr. Barker is a finance professional with general management experience. Mr. Barker was Senior Vice President and Chief Financial Officer of Zenon Environmental Inc. from 2000 to 2006. He was responsible for managing the finance and information technology of over 35 subsidiary companies in 25 different countries. He led teams that raised over $140 million between 2002 and 2004, and assisted in the sale of Zenon Environmental Inc. to General Electric Company. He currently sits on the Board of Directors, and serves as Chair of the Compensation Committee, of Titan Medical Inc. a TSX listed company. Mr. Barker is a Fellow of the Chartered Professional Accountants of Canada (Fellow of the Certified Management Accountants). 

 

mhubbesMartin Hubbes
Independent Director

Mr. Hubbes brings decades of investment industry and capital markets experience to the Board. As Executive Vice President and Chief Investment Officer at AGF Investments, he led a team of investment professionals managing more than $35 billion in assets. Prior to his appointment as CIO in 2005, he was a Portfolio Manager at AGF overseeing an investment portfolio of more than $5 billion. Mr. Hubbes currently manages personal investments in early-stage companies.

 

plucasPaul Lucas
Chairman of the Board of Directors & Independent Director

Mr. Lucas served as President and CEO of GlaxoSmithKline Canada from 1994 until 2012, where he was responsible for all pharmaceutical operations in Canada. During his time with GSK, he built the company into a national manufacturing leader, producing and shipping more than CAD $2 billion worth of products, representing approximately 25 per cent of the total Canadian pharmaceutical shipments. Previous to joining Glaxo Canada in 1986, he held progressive management positions at Eli Lilly Canada and McNeil Pharmaceutical. Mr. Lucas sits on the Board of Directors for the Ontario Genomic Institute, was Chairman and member of the Board of Directors for TM Bioscience, was on the Board of Directors of the Toronto Regional Research Alliance and is a member of the Principal's Advisory Council of the University of Toronto at Mississauga. He served in the past as Chairman of the Board of Directors of Canada's Research-Based Pharmaceutical Companies (Rx&D). He received his B.Sc. (Honours) in Biology and Chemistry from Queen's University, and obtained his Chartered Directors designation (CDir) from the Directors College, a joint venture of McMaster University and the Conference Board of Canada, in 2009.

 

Jeff MacDonald
Chief Executive Officer

Jeff MacDonald is Chief Executive Officer of EcoSynthetix. Prior to this role, Mr. MacDonald was the company’s Chief Operating Officer. Mr. MacDonald came to EcoSynthetix with more than 15 years of executive leadership experience in a variety of roles, including operations, business development, and marketing. He spent the majority of his career at Husky Injection Molding Systems, a leading manufacturer of equipment and services for the plastics industry, with more than $1 billion in annual sales. At Husky, Mr. MacDonald led the establishment of new businesses, introduced a number of new products to market and led key initiatives that had a transformational impact on overall business performance. Mr. MacDonald holds a Master of Business Administration degree from McMaster University and a Bachelor of Science degree from the University of Western Ontario.

 

jnodlandJeffrey Nodland
Independent Director

Mr. Nodland was appointed to the Board of Directors of EcoSynthetix as of January 1, 2016. Mr. Jeffrey Nodland joins EcoSynthetix as an independent board member. Mr. Nodland is President and CEO of KIK Custom Products, one of North America’s largest custom manufacturers of both national and retailer-branded consumer products, with annual sales of more than $2.0 billion. Mr. Nodland’s career spans more than 30 years in specialty chemicals and coatings manufacturing, serving in executive leadership positions at companies such as Valspar Corporation, Hexion Specialty Chemicals, Inc., Resolution Performance Products, and McWhorter Technologies, a specialty chemicals company acquired by Eastman Chemical. In addition, Mr. Nodland serves on the Board of Directors of MPM Holdings Inc. Previously, Mr. Nodland served as a member of the Board of Directors of California Products Corporation and Texas Petrochemicals Group.